|
⚲
|
| Keyboard |
| McKenna Mark C
✚
|
|
|---|---|
| CIK # | 0001749623 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001749623] | |
| 4 | [0001749623] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2026-01-07 | Grant | 15,300 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2026-01-07 | Grant | 3,400 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 30,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Option exercise | 30,000 | ||
|
Apogee Therapeutics Inc APGE
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 14,461 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 25,000 | $0.00 | |
|
NewAmsterdam Pharma Co NV NAMS
Ordinary Shares
|
2025-01-07 | Grant | 6,960 | ||
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2025-01-06 | Grant | 32,500 | $0.00 | |
|
Apogee Therapeutics Inc APGE
Common Stock
|
2024-12-12 | Buy | 12,500 | $49.85 | 623,125 |
|
Apogee Therapeutics Inc APGE
Common Stock
|
2024-12-12 | Buy | 7,500 | $49.02 | 367,650 |
|
NewAmsterdam Pharma Co NV NAMS
Option (right to buy) · derivative
|
2024-07-17 | Grant | 72,500 | $0.00 | |
|
Apogee Therapeutics Inc APGE
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 10,370 | $0.00 | |
|
Spyre Therapeutics Inc SYRE
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 40,000 | $0.00 | |
|
Apogee Therapeutics Inc APGE
Stock Option (Right to Buy) · derivative
|
2023-08-17 | Grant | 100,000 | $0.00 | |
|
Apogee Therapeutics Inc APGE
Stock Option (Right to Buy) · derivative
|
2023-08-17 | Grant | 50,000 | $0.00 | |
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 566,307 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 246,639 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 290,000 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 132,741 | ||
|
Prometheus Biosciences Inc RXDX
Stock Option (right to buy) · derivative
|
2023-06-16 | Disposed to issuer | 128,930 | ||
| showing 20 of 62 most recent transactions | |||||